0001209191-23-054170.txt : 20231102
0001209191-23-054170.hdr.sgml : 20231102
20231102165300
ACCESSION NUMBER: 0001209191-23-054170
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231101
FILED AS OF DATE: 20231102
DATE AS OF CHANGE: 20231102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krebs Stephanie
CENTRAL INDEX KEY: 0001998150
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39980
FILM NUMBER: 231373311
MAIL ADDRESS:
STREET 1: C/O SENSEI BIOTHERAPEUTICS, INC.
STREET 2: 1405 RESEARCH BLVD, SUITE 125
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sensei Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001829802
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1405 RESEARCH BLVD, SUITE 125
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: (240) 243-8000
MAIL ADDRESS:
STREET 1: 1405 RESEARCH BLVD, SUITE 125
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-11-01
0
0001829802
Sensei Biotherapeutics, Inc.
SNSE
0001998150
Krebs Stephanie
C/O SENSEI BIOTHERAPEUTICS, INC.
1405 RESEARCH BLVD, SUITE 125
ROCKVILLE
MD
20850
0
1
0
0
Chief Business Officer
0
Stock Option (Right to Buy)
0.82
2023-11-01
4
A
0
125000
0.00
A
2033-10-31
Common Stock
125000
125000
D
The shares subject to the option vest and become exercisable as to 25% of the shares underlying the option on November 1, 2024, and the remaining 75% of the shares underlying the Option shall vest and become exercisable in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
/s/ Mark Ballantyne, Attorney-in-Fact
2023-11-02